4.6 Article

Hibernation in a primate: does sleep occur?

期刊

ROYAL SOCIETY OPEN SCIENCE
卷 3, 期 8, 页码 -

出版社

ROYAL SOC
DOI: 10.1098/rsos.160282

关键词

REM; non-REM; metabolic rates; primate; lemur; hibernation

资金

  1. Duke Provost's Common Fund
  2. Duke Institute for Brain Sciences
  3. Duke Institute for Genome Sciences and Policy
  4. Duke Lemur Center
  5. Duke Department of Psychiatry and Behavioral Science
  6. Margot Marsh Biodiversity Foundation
  7. DFG (German Research Foundation) [DA 1013/6-1]

向作者/读者索取更多资源

During hibernation, critical physiological processes are downregulated and thermogenically induced arousals are presumably needed periodically to fulfil those physiological demands. Among the processes incompatible with a hypometabolic state is sleep. However, one hibernating primate, the dwarf lemur Cheirogaleus medius, experiences rapid eye movement (REM)-like states during hibernation, whenever passively reaching temperatures above 30 degrees C, as occurs when it hibernates in poorly insulated tree hollows under tropical conditions. Here, we report electroencephalographic (EEG) recordings, temperature data and metabolic rates from two related species (C. crossleyi and C. sibreei), inhabiting high-altitude rainforests and hibernating underground, conditions that mirror, to some extent, those experienced by temperate hibernators. We compared the physiology of hibernation and spontaneous arousals in these animals to C. medius, as well as the much more distantly related non-primate hibernators, such as Arctic, golden-mantled and European ground squirrels. We observed a number of commonalities with non-primate temperate hibernators including: (i) monotonous ultra-low voltage EEG during torpor bouts in these relatively cold-weather hibernators, (ii) the absence of sleep during torpor bouts, (iii) the occurrence of spontaneous arousals out of torpor, during which sleep regularly occurred, (iv) relatively high early EEG non-REM during the arousal, and (v) a gradual transition to the torpid EEG state from non-REM sleep. Unlike C. medius, our study species did not display sleep-like states during torpor bouts, but instead exclusively exhibited them during arousals. During these short euthermic periods, non-REM as well as REM sleep-like stages were observed. Differences observed between these two species and their close relative, C. medius, for which data have been published, presumably reflect differences in hibernaculum temperature.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Chronobiologic parameter changes in patients with major depressive disorder and sleep disturbance treated with adjunctive brexpiprazole: An open-label, flexible-dose, exploratory substudy

Andrew D. Krystal, Aurelia Mittoux, Annika Lindsten, Ross A. Baker

Summary: The study indicates that adjunctive brexpiprazole may help correct circadian dysfunction in patients with MDD. The phase angle between peak cortisol and DLMO could be a potential biomarker for depression and therapeutic response.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Article Biochemistry & Molecular Biology

State-dependent responses to intracranial brain stimulation in a patient with depression

Katherine W. Scangos, Ghassan S. Makhoul, Leo P. Sugrue, Edward F. Chang, Andrew D. Krystal

Summary: Deep brain stimulation shows promise in treating severe depression, but questions about anatomical targeting remain. A study implanting intracranial electrodes in a depressed patient found rapid, reproducible emotional responses that were context and state dependent, providing proof of concept for personalized, circuit-specific medicine in psychiatry.

NATURE MEDICINE (2021)

Article Clinical Neurology

Optimizing computation of overnight decline in delta power: Evidence for slower rate of decline in delta power in insomnia patients

Jessica R. Lunsford-Avery, Jack D. Edinger, Andrew D. Krystal

Summary: The study found that using all available NREM epochs in computing Delta Decline is the best method for minimizing the effects of missing data. Insomnia patients displayed slower Delta Decline rates compared to healthy controls, suggesting a potential indicator of insomnia.

CLINICAL NEUROPHYSIOLOGY (2021)

Correction Neurosciences

Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS) (Aug, 10.1038/s41386-021-01145-9, 2021)

Diego A. Pizzagalli, Moria Smoski, Yuen-Siang Ang, Alexis E. Whitton, Gerard Sanacora, Sanjay J. Mathew, John Nurnberger, Sarah H. Lisanby, Dan V. Iosifescu, James W. Murrough, Hongqiu Yang, Richard D. Weiner, Joseph R. Calabrese, Wayne Goodman, William Z. Potter, Andrew D. Krystal

NEUROPSYCHOPHARMACOLOGY (2021)

Article Clinical Neurology

Randomized controlled trial of digital cognitive behavior therapy for prenatal insomnia symptoms: effects on postpartum insomnia and mental health

Jennifer N. Felder, Elissa S. Epel, John Neuhaus, Andrew D. Krystal, Aric A. Prather

Summary: The study examines the effects of digital cognitive behavior therapy for insomnia (dCBT-I) during pregnancy on subjective sleep outcomes, depressive symptoms, and anxiety symptoms. The findings suggest that dCBT-I can improve postpartum insomnia remission rates and reduce the incidence of insomnia. Additionally, dCBT-I shows significant improvements in depressive and anxiety symptom severity, particularly among patients with minimal depressive symptoms at baseline.
Article Medicine, Research & Experimental

Telemedicine-delivered cognitive-behavioral therapy for insomnia in alcohol use disorder (AUD): study protocol for a randomized controlled trial

J. Todd Arnedt, M. Elizabeth Cardoni, Deirdre A. Conroy, Mandilyn Graham, Sajni Amin, Kipling M. Bohnert, Andrew D. Krystal, Mark A. Ilgen

Summary: This trial aims to compare the effects of telemedicine-delivered CBT for insomnia (CBT-TM) and sleep hygiene education (SHE-TM) on improving insomnia/sleep, daytime symptoms, and drinking outcomes in treatment-seeking adults with AUD and insomnia. The study will also examine the impact of treatment on sleep mechanisms and their association with clinical outcomes.

TRIALS (2022)

Article Clinical Neurology

Overnight Delta Dynamics Associated with Daytime Psychomotor Performance in Adults with Insomnia and Healthy Controls

Jessica R. Lunsford-Avery, Jack D. Edinger, Andrew D. Krystal

Summary: Sleep EEG factors, such as overnight delta decline and initial delta peak, contribute significantly to psychomotor functioning in adults with insomnia and healthy controls. These factors, along with sleep duration and continuity, support cognitive restoration during sleep and daytime functioning.

NATURE AND SCIENCE OF SLEEP (2022)

Article Medicine, General & Internal

Trajectories of Insomnia in Adults After Traumatic Brain Injury

Emerson M. Wickwire, Jennifer S. Albrecht, Vincent F. Capaldi, Sonia O. Jain, Raquel C. Gardner, J. Kent Werner, Pratik Mukherjee, Ashlee B. McKeon, Michael T. Smith, Joseph T. Giacino, Lindsay D. Nelson, Scott G. Williams, Jacob Collen, Xiaoying Sun, David M. Schnyer, Amy J. Markowitz, Geoffrey T. Manley, Andrew D. Krystal

Summary: This study identifies unique trajectories of insomnia in adults after traumatic brain injury (TBI) using latent class mixed models (LCMM). The results show that there is heterogeneity in the course of insomnia after TBI, with different trajectory classes including persistent mild insomnia, initially mild insomnia that resolves over time, persistent severe insomnia, initially severe insomnia that resolves by 12 months, and initially no insomnia symptoms but develop severe symptoms by 12 months. Factors such as female sex, Black race, history of psychiatric illness, and intracranial injury are significantly associated with insomnia trajectory class membership.

JAMA NETWORK OPEN (2022)

Correction Biochemistry & Molecular Biology

State-dependent responses to intracranial brain stimulation in a patient with depression (vol 27, pg 229, 2021)

Katherine W. Scangos, Ghassan S. Makhoul, Leo P. Sugrue, Edward F. Chang, Andrew D. Krystal

NATURE MEDICINE (2022)

Article Psychiatry

Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression

Andrew D. Krystal, Ruth M. Benca, Russell Rosenberg, Paula K. Schweitzer, Atul Malhotra, Kimberly Babson, Lawrence Lee, Shay Bujanover, Kingman P. Strohl

Summary: This study compares the effects of solriamfetol treatment on excessive daytime sleepiness (EDS) in individuals with and without a history of depression. The findings show that depression history does not affect the safety and efficacy of solriamfetol in treating EDS associated with narcolepsy or obstructive sleep apnea (OSA). Additionally, the study highlights the high prevalence of depression in individuals with sleep disorders and suggests the importance of recognizing this association in a clinical setting.

JOURNAL OF PSYCHIATRIC RESEARCH (2022)

Letter Clinical Neurology

Changes in intracranial neurophysiology associated with acute COVID-19 infection

Kristin K. Sellers, Noah Stapper, Daniela A. Astudillo Maya, Catherine Henderson, Ankit N. Khambhati, Joline M. Fan, Vikram R. Rao, Katherine W. Scangos, Edward F. Chang, Andrew D. Krystal

CLINICAL NEUROPHYSIOLOGY (2023)

Article Clinical Neurology

Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program

C. Neill Epperson, David R. Rubinow, Samantha Meltzer-Brody, Kristina M. Deligiannidis, Robert Riesenberg, Andrew D. Krystal, Kemi Bankole, Ming-Yi Huang, Haihong Li, Colville Brown, Stephen J. Kanes, Robert Lasser

Summary: The study demonstrates that Brexanolone is associated with rapid improvement in depressive symptoms and symptoms of anxiety and insomnia compared with placebo in women with postpartum depression.

JOURNAL OF AFFECTIVE DISORDERS (2023)

Review Medicine, General & Internal

What Should Be the Focus of Treatment When Insomnia Disorder Is Comorbid with Depression or Anxiety Disorder?

Charles M. Morin, Suzanne M. Bertisch, Rafael Pelayo, Nathaniel F. Watson, John W. Winkelman, Phyllis C. Zee, Andrew D. Krystal

Summary: Insomnia is a significant public health problem that is often undiagnosed and untreated. Treatment practices are not always evidence-based, particularly when insomnia coexists with anxiety or depression. There is a gap between current clinical practices and evidence-based guidelines, highlighting the need for more awareness and distinct treatment of insomnia from comorbid psychiatric conditions.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Psychology, Clinical

Diagnosing and Treating Insomnia in Adults and Older Adults

Russell P. Rosenberg, Andrew D. Krystal

JOURNAL OF CLINICAL PSYCHIATRY (2021)

Article Clinical Neurology

Cost-effectiveness of digital cognitive behavioral therapy (Sleepio) for insomnia: a Markov simulation model in the United States

Michael Darden, Colin A. Espie, Jenna R. Carl, Alasdair L. Henry, Jennifer C. Kanady, Andrew D. Krystal, Christopher B. Miller

Summary: The study found that fully automated digital cognitive behavioral therapy (CBT) is the most cost-effective treatment for insomnia in the United States, followed by group CBT, pharmacotherapy, and individual CBT. Utilizing automated digital CBT to treat insomnia at a population scale is financially prudent and beneficial from a societal perspective.
暂无数据